Table of Contents
1. Overview
- 1.1 Objectives
- 1.2 Scope
- 1.3 Methodology
- 1.4 Executive Summary
2. Medical Imaging Market Analysis
- 2.1 Medical Imaging Industry Market Size
- 2.2 Medical Imaging Infrastructure
- 2.2.1 Total Healthcare Expenditures and Demographics
- 2.2.2 Number of Hospitals
- 2.2.3 Number of Radiologists
- 2.2.4 Radiology Services
- 2.2.5 Medical Imaging Companies
- 2.2.6 Market Drivers
- 2.2.6.1 Product Enhancements
- 2.2.6.2 Contrast Agents Development
- 2.2.6.3 Innovation
- 2.2.7 Market Restraints
- 2.2.8 Market Segments for Medical Imaging
- 2.2.8.1 Discovery
- 2.2.8.2 Clinical Applications
- 2.2.8.3 Clinical Trials
- 2.2.8.4 Outpatient Facilities
- 2.2.8.5 Technology Advances in Diagnostic Imaging Modalities
- 2.2.8.6 Safety and Ergonomics Concerns
- 2.2.8.7 Volumetric Imaging
- 2.2.8.8 Digital Radiography (DR)
- 2.2.8.9 Contrast Media
3. Nuclear Medicine and Nuclear Cardiology Market
- 3.1 Medical Imaging Industry Forecasts
- 3.2 Hardware Companies (Nuclear Medicine Instrumentation)
- 3.3 Software Companies (Image Processing and PACS)
- 3.4 Radiopharmaceuticals and Pharmaceuticals Companies
- 3.5 Ancillary Products Companies
- 3.6 Service and Support Companies
- 3.7 Nuclear Cardiology Market
- 3.8 Hardware (PET, SPECT and Hybrids)
- 3.8.1 Scanner Investment: Not Just a Cardiology Market
- 3.8.1.1 Impact of Alzheimer' s Reimbursement
- 3.8.2 Sales Trends for PET Scanners
- 3.8.3 Market Consolidation in the U.S.
- 3.8.4 Learning Curve Impact for PET
- 3.8.5 Hardware Market Trends
- 3.9 Software (PACS and RIS)
- 3.10 Radiopharmaceuticals
- 3.10.1 Diagnostic Radiopharmaceuticals
- 3.10.2 Therapeutic Radiopharmaceuticals
4. Products Analysis
- 4.1 Nuclear Medicine Instrumentation
- 4.1.1 PET Scan
- 4.1.2 SPECT Scan
- 4.1.3 PET Versus SPECT
- 4.1.4 Hybrid Technology
- 4.2 Image Processing: PACS
- 4.2.1 PACS and Nuclear Medicine
- 4.2.2 Difficulties in Making PACS Work with Nuclear Medicine
- 4.2.1.2 3-D and Quantitative Analysis
- 4.2.1.5 Small Market Opportunities
- 4.3 Radiopharmaceuticals and Pharmaceuticals
- 4.3.1 Introduction
- 4.3.2 Background
- 4.3.3 Areas of Current Interest
5. Regulations, Reimbursements and Other Issues
- 5.1 Food and Drug Administration (FDA)
- 5.1.1 FDA Guidance
- 5.1.2 FDA Nuclear Medicine Coalition
- 5.2 U.S. Nuclear Regulatory Commission (NRC)
- 5.2.1 What NRC Regulates
- 5.2.2 How NRC Regulates
- 5.2.3 Related Information
- 5.3 Memorandum of Understanding between NRC and FDA
- 5.3.1 Authorities and Regulatory Programs
- 5.4 Current NRC Issues and Actions
- 5.4.1 Meetings
- 5.4.2 Program and Policy Issues
- 5.4.3 Recently Issued Significant Enforcement Actions
- 5.4.3.1 Stark II Regulations
- 5.4.3.2 Recent Impact of Stark II Regulations
- 5.4.3.3 Reimbursement
6. Business Affairs (Mergers, Acquisitions and Partnerships)
- 6.1 Recent Corporate Partnerships and Mergers
- 6.2 Recent Industry Activity
- 6.3 Product Launches and Developments
7. Technology Trends
- 7.1 Hardware (Nuclear Medicine Instrumentation)
- 7.2 Software (PACS)
- 7.2.1 Problems Interfacing PACS and NM
- 7.2.2 SNM and IHE
- 7.2.3 IHE Nuclear Medicine Profile
- 7.2.4 What Next?
- 7.2.5 Optimal Patient Care
- 7.2.6 Four Steps to Standards Adoption
- 7.2.7 Technical Framework: Business with Technology
- 7.2.8 Leading by Example
- 7.2.9 IHE and Electronic Health Record (EHR)
- 7.3 Radiopharmaceuticals and Pharmaceuticals
- 7.3.1 Market Share
- 7.3.2 Contrast Media Market Drivers
- 7.3.3 Contrast Media Market Sector Overview
- 7.3.4 Contrast Media Market Analysis
- 7.3.5 Growth Prospects for Contrast Media
- 7.4 Market Sector Analysis
- 7.5 Leading Companies in General Medical Imaging
8. Company Profiles
- 8.1 Hardware (Nuclear Medicine Instrumentation)
- 8.1.1 AccuSync Medical Research
- 8.1.2 Bristol-Myers Squibb (Medical Imaging)
- 8.1.3 Capintec
- 8.1.4 CardiArc
- 8.1.5 Cardinal Health (Cardiology Solutions)
- 8.1.6 Digirad
- 8.1.7 GE Healthcare
- 8.1.8 GVI Medical Devices
- 8.1.9 Hitachi Medical Systems America
- 8.1.10 IS2 Medical Systems
- 8.1.11 Mediso
- 8.1.12 Philips Medical
- 8.1.13 Positron
- 8.1.14 Siemens Medical
- 8.1.15 Spectrum Dynamics
- 8.2 Software (Image Processing and PACS)
- 8.2.1 Heartlab
- 8.2.2 Hermes Medical Solutions
- 8.2.3 INVIA
- 8.2.4 McKesson
- 8.2.5 MedImage
- 8.2.6 MIMvista
- 8.2.7 Numa
- 8.2.8 ProSolv Cardiovascular
- 8.2.9 Scientific Imaging
- 8.2.10 Segami Corporation
- 8.2.11 Syntermed
- 8.2.12 Thinking Systems Corporation
- 8.2.13 UltraSPECT
- 8.2.14 Witt Biomedical Corporation
- 8.3 Radiopharmaceuticals and Pharmaceuticals
- 8.3.1 Astellas Pharma U.S.
- 8.3.2 Bracco Diagnostics
- 8.3.3 Isotope Products Laboratories
- 8.3.4 Izotop: Institute of Isotopes
- 8.3.5 Mallinckrodt
- 8.3.6 Merck
- 8.3.7 NuView Radiopharmaceuticals
- 8.3.8 Pfizer
- 8.3.9 Tyco Healthcare
- 8.4 Ancillary Products
- 8.4.1 CNMTStore.com
- 8.4.2 Data Spectrum Corporation
- 8.4.3 Daxor Corporation
- 8.4.4 Ivy Biomedical Systems
- 8.4.5 MarCal Medical
- 8.5 Service and Support
- 8.5.1 BC Technical
- 8.5.2 Diagnostix Plus
- 8.5.3 MedAxiom
- 8.5.4 MediNuclear Corporation (MNC)
- 8.5.5 MEDX
- 8.5.6 Pinestar Technology
- 8.5.7 Technology Imaging Services
- 8.6 Other Business Opportunities
9. Other Elements of Nuclear Medicine Industry
- 9.1 Nuclear Medicine: Guidelines, Certification and Societies
- 9.1.1 American College of Radiology (ACR)
- 9.1.2 American Society of Nuclear Cardiology (ASNC)
- 9.1.3 Associates in Medical Physics (AMP)
- 9.1.4 Certification Board of Nuclear Cardiology (CBNC)
- 9.1.5 ICANL
- 9.1.6 IHE
- 9.1.7 ISO
- 9.1.8 MedPage Today
- 9.1.9 Nuclear Medicine Technology Certification Board (NMTCB)
- 9.1.10 Society of Cardiovascular Computed Tomography (SCCT)
- 9.1.11 Society of Nuclear Medicine (SNM)
- 9.2 Nuclear Medicine: Publications
- 9.2.1 Elsevier
- 9.2.2 HRA Research
- 9.2.3 Lippincott Williams & Wilkins
INDEX OF FIGURES
- Figure 3.1: U.S. Nuclear Imaging Procedures
- Figure 3.2: Digirad--Growth of Nuclear Imaging Procedures, 2004-2006
- Figure 4.1: Nuclear Imaging
- Figure 4.2: PET Scan
- Figure 4.3: SPECT Scan
- Figure 4.4: PET-CT Scan
- Figure 4.5: SPECT-CT Scan
- Figure 7.1: IHE Technical Framework
- Figure 7.2: IHE Framework Organization
- Figure 7.3: IHE Actors and Transactions
INDEX OF TABLES
- Table 2.1: U.S. Medical Imaging Market Size, 2001-2010
- Table 2.2: Global Medical Imaging Market Size, 2001-2010
- Table 2.3: U.S. Health Expenditures as a Percentage of GDP, 2000-2010
- Table 2.4: U.S. User Expenditures for Medical Imaging Equipment and
Related Products
- Table 2.5: Millions of Americans Over 65 Years of Age, 2000-2050
- Table 2.6: Hospital Survey
- Table 2.7: Percent Change in Volume of Examinations per Imaging Modality,
1993-2004
- Table 2.8: Worldwide Market Share of Medical Imaging Companies
- Table 2.9: Worldwide Imaging Procedures, 2001 to 2010
- Table 2.10: Data Sources for Nuclear Medicine Professionals and Facilities
- Table 7.1: Market Share of Contrast Media Players
- Table 7.2: Contrast Media Market Growth, 2003-2010
- Table 7.3: Worldwide Imaging Procedures, 2001-2010
- Table 8.1: Astellas Alliances
|
Related Report
|